Erste Asset Management GmbH »

Akero Therapeutics shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.3M 47k 28.24
2024-06-30 $1.1M 47k 23.40
2024-03-31 $1.1M 47k 24.45
2023-12-31 $1.1M 47k 24.02

More positions owned by Erste Asset Management GmbH

Nvidia Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Meta Platforms Common Stock (META)
Unitedhealth Group Incorporated Common Stock (UNH)
Netflix Common Stock (NFLX)
Visa Common Stock (V)
Adobe Common Stock (ADBE)
The Progressive Corporation Common Stock (PGR)
Broadcom Common Stock (AVGO)
Agios Pharmaceuticals Common Stock (AGIO)
Lam Research Corporation Common Stock (LRCX)
Kla Corporation Common Stock (KLAC)
Amazon.com Common Stock (AMZN)

View all positions for Erste Asset Management GmbH

Top funds holding Akero Therapeutics

Henderson Group
BlackRock
BlackRock
General Atlantic
T. Rowe Price Associates
Vanguard Group
State Street Corporation
Alliancebernstein
Perceptive Advisors
Boxer Capital
Geode Capital Management
Redmile Group
Point72 Asset Management
T. Rowe Price Investment Management
Baker Bros. Advisors

View all funds holding Akero Therapeutics